HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) A correction has been published Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (18) Citing Articles via Google Scholar Google Scholar Articles by Ripoli, A. Articles by Iervasi, G. Search for Related Content PubMed PubMed Citation Articles by Ripoli, A. Articles by Iervasi, G.

CLINICAL RESEARCH: CARDIAC MAGNETIC RESONANCE

Does subclinical hypothyroidism affect cardiac pump performance?

Evidence from a magnetic resonance imaging study

Andrea Ripoli, PhD^*, Alessandro Pingitore, MD, PhD^*,*, Brunella Favilli, MSc^*, Antonio Bottoni, MD^*, Stefano Turchi, BSc^*, Nael F. Osman, PhD, Daniele De Marchi, RT^*, Massimo Lombardi, MD^*, Antonio L'Abbate, MD and Giorgio Iervasi, MD^*

^* Institute of Clinical Physiology, C.N.R., Pisa, Italy
Johns Hopkins University, Baltimore, Maryland
Scuola Superiore S. Anna and Institute of Clinical Physiology, C.N.R., Pisa, Italy

Manuscript received March 2, 2004; revised manuscript received October 1, 2004, accepted October 18, 2004.

^* Reprint requests and correspondence: Dr. Alessandro Pingitore, C.N.R. Clinical Physiology Institute, S. Cataldo Research Campus, Via G. Moruzzi 1, 56124, Pisa Italy (Email: pingi{at}ifc.cnr.it).

OBJECTIVES: We sought to assess the effects of subclinical hypothyroidism (SHT) on the cardiac volumes and function.

BACKGROUND: The cardiovascular system is one of the principal targets of thyroid hormones. Subclinical hypothyroidism is a common disorder that may represent "early" thyroid failure.

METHODS: Thyroid profile was evaluated in 30 females with SHT and 20 matched control subjects. Left ventricular end-diastolic volume (EDV) and end-systolic volume (ESV), stroke volume (SV), cardiac index (CI), and systemic vascular resistance (SVR) were calculated by cardiac magnetic resonance (CMR). Regional greatest systolic lengthening (E1) and greatest systolic shortening (E2) were calculated by tagging CMR.

RESULTS: EDV was lower in SHT than in controls (64.3 ± 8.7 ml/m² vs. 81.4 ± 11.3 ml/m², p < 0.001), as well as SVR (38.9 ± 7.5 ml/m² vs. 52.5 ± 6.1 ml/m², p < 0.001) and CI (2.6 ± 0.5 l/[min·m²] vs. 3.7 ± 0.4 l/[min·m²], p < 0.001). Systemic vascular resistance was higher in SHT (12.5 ± 2.5 mm Hg·min/[l·m²] vs. 8.6 ± 1.1 mm Hg·min/[l·m²], p = 0.003). The E1 was higher in controls than in SHT at the basal (p = 0.007), equatorial (p = 0.05), and apical (p = 0.008) levels, as well as E2 at the equatorial (p = 0.001) and apical (p = 0.001) levels. All parameters normalized after replacement therapy. A negative correlation between TSH and EDV (p < 0.001), SV (p < 0.001), CI (p < 0.001), and E1 at the apical level (p < 0.001) and a positive correlation between TSH and SVR (p < 0.001) and E2 at the apical level (p < 0.001) were found.

CONCLUSIONS: Subclinical hypothyroidism significantly decreased cardiac preload, whereas it increased afterload with a consequent reduction in SV and cardiac output. Replacement therapy fully normalized the hemodynamic alterations.

Abbreviations and Acronyms   CI = cardiac index   CMR = cardiac magnetic resonance   DWT = diastolic wall thickness   E1 = greatest systolic lengthening   E2 = greatest systolic shortening   EDV = end-diastolic volume   ESV = end-systolic volume   FT3 = free tri-iodothyronine   FT4 = free thyroxine   LV = left ventricular   SHT = subclinical hypothyroidism   SV = stroke volume   SVR = systemic vascular resistance   TSH = thyroid-stimulating hormone

This article has been cited by other articles:

				B. Biondi and D. S. Cooper The Clinical Significance of Subclinical Thyroid Dysfunction Endocr. Rev., February 1, 2008; 29(1): 76 - 131. [Abstract] [Full Text] [PDF]

				V. Lionetti, L. Guiducci, A. Simioniuc, G. D. Aquaro, C. Simi, D. De Marchi, S. Burchielli, L. Pratali, M. Piacenti, M. Lombardi, et al. Mismatch between uniform increase in cardiac glucose uptake and regional contractile dysfunction in pacing-induced heart failure Am J Physiol Heart Circ Physiol, November 1, 2007; 293(5): H2747 - H2756. [Abstract] [Full Text] [PDF]

				M. D. Gammage, J. V. Parle, R. L. Holder, L. M. Roberts, F. D. R. Hobbs, S. Wilson, M. C. Sheppard, and J. A. Franklyn Association Between Serum Free Thyroxine Concentration and Atrial Fibrillation Arch Intern Med, May 14, 2007; 167(9): 928 - 934. [Abstract] [Full Text] [PDF]

				G. Enia, V. Panuccio, S. Cutrupi, P. Pizzini, G. Tripepi, F. Mallamaci, and C. Zoccali Subclinical hypothyroidism is linked to micro-inflammation and predicts death in continuous ambulatory peritoneal dialysis Nephrol. Dial. Transplant., February 1, 2007; 22(2): 538 - 544. [Abstract] [Full Text] [PDF]

				N. E. Buroker, M. E. Young, C. Wei, K. Serikawa, M. Ge, X.-H. Ning, and M. A. Portman The dominant negative thyroid hormone receptor beta-mutant {Delta}337T alters PPAR{alpha} signaling in heart Am J Physiol Endocrinol Metab, February 1, 2007; 292(2): E453 - E460. [Abstract] [Full Text] [PDF]

				P. J. D. Owen, C. Rajiv, D. Vinereanu, T. Mathew, A. G. Fraser, and J. H. Lazarus Subclinical Hypothyroidism, Arterial Stiffness, and Myocardial Reserve J. Clin. Endocrinol. Metab., June 1, 2006; 91(6): 2126 - 2132. [Abstract] [Full Text] [PDF]